A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma
- 1 July 2012
- journal article
- research article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 13 (9) , 776-781
Abstract
Anaplastic thyroid carcinoma (ATC) is an extremely aggressive and rapidly fatal neoplasm. The aim of this study was to identify a limited cell cycle associated protein expression pattern unique to ATC and to correlate that pattern with clinical outcome. This represents one of the largest tissue micro-array projects comparing the cell cycle protein expression data of ATC to other well-differentiated tumors in the literature. Tissue microarrays were created from 21 patients with ATC and an age and gender matched cohort of patients with papillary thyroid carcinoma (PTC). Expression of epidermal growth factor receptor, cyclin D1, cyclin E, p53, p21, p16, aurora kinase A, opioid growth factor (OGF), OGF-receptor, thyroglobulin and Ki-67 was evaluated in a semi-quantitative fashion. Differences in protein expression between the cohorts were evaluated using chi-square tests with Bonferroni adjustments. Survival time and presence of metastasis at presentation were collected. The ATC cohort showed a statistically significant decrease (p < 0.05) in thyroglobulin expression and statistically significant increases (p < 0.05) in Ki-67 and p53 expression as compared with the PTC cohort. A trend toward loss of p16 and p21 expression was noted in the ATC cohort. A trend toward decreased survival was noted with p21 expression. These data indicate disruption of the normal cell cycle with aberrant expression of multiple protein markers suggesting increased proliferative activity and loss of control of cell cycle progression to G1 phase. These findings support the assertion that ATC may represent the furthest end of a continuum of thyroid carcinoma dedifferentiation.Keywords
This publication has 21 references indexed in Scilit:
- Cell Cycle Regulators Show Diagnostic and Prognostic Utility for Differentiated Thyroid CancerAnnals of Surgical Oncology, 2007
- Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological informationOncogene, 2007
- Anaplastic Carcinoma of the Thyroid Arising More Often from Follicular Carcinoma than Papillary CarcinomaAnnals of Surgical Oncology, 2007
- Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progressionSurgery, 2006
- Anaplastic Thyroid Carcinoma: Expression Profile of Targets for Therapy Offers New Insights for Disease TreatmentAnnals of Surgical Oncology, 2006
- Epidermal growth factor receptor status in anaplastic thyroid carcinomaJournal of Clinical Pathology, 2006
- Expression of Aurora kinases in human thyroid carcinoma cell lines and tissuesInternational Journal of Cancer, 2006
- Coexistent Anaplastic and Differentiated Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2006
- Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment ApproachesAnnals of Surgical Oncology, 2006
- Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapyHead & Neck, 2003